Announcements Trials
Browse Landscape

Phase

Phase 1 7Phase 2 5Phase EARLY_PHASE1 2Phase NA 1Phase 4 1Phase 3 1Phase 1/2 1

Status

Terminated 1Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 16Genitourinary 13Gastrointestinal 11Sarcoma 6Breast 6Head & Neck 5Gynecologic 5Thoracic 4Lymphoid 4Dermatologic 3Tumor-Agnostic 2Other solid neoplasm 2Other hematologic neoplasm 2NET 2Endocrine 2

Conditions

Neuroendocrine Tumors 2von Hippel-Lindau Disease 1Multiple Endocrine Neoplasia Type 1 1Meningioma 1

Interventions

gallium Ga 68 dotatate 690Y-octreotide, DOTA-Tyr(3)- 3Single Photon Emission Computed Tomography Computed Tomography 2Magnetic Resonance Spectroscopy 23-Iodobenzylguanidine 2lutetium Lu 177 dotatate 1lanreotide 1Tomography, X-Ray Computed 1Tomography, Emission-Computed, Single-Photon 1Positron-Emission Tomography 1Positron Emission Tomography Computed Tomography 1Metformin 1Iodine-123 1Ga(III)-DOTATOC 168Ga-pentixafor 168Ga-FAPI 164Cu-SARTATE 13-fluorobenzylguanidine 1177Lu-octreotide, DOTA(0)-Tyr(3)- 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Magnetic Resonance Spectroscopy × NET × Clear all
NCT07132645 2025-09-23

An Investigational Scan ([68Ga] Ga-FAPI-04 PET/CT) for the Imaging of Patients With High-Grade Neuroendocrine Cancer

University of Michigan Rogel Cancer Center

Phase EARLY_PHASE1 Recruiting
30 enrolled
EndocrineNET

Neuroendocrine Tumors

NCT03001349 2021-02-15

68Ga-DOTA-TOC PET/CT in Imaging Participants With Neuroendocrine Tumors

M.D. Anderson Cancer Center

Phase EARLY_PHASE1 Terminated
4 enrolled
CNSEndocrineNET

von Hippel-Lindau Disease, Meningioma, Neuroendocrine Tumors, Multiple Endocrine Neoplasia Type 1

Data powered by HemOnc (CC BY 4.0) Colophon âš¡